Bookmark
Forward
Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa.
Dermatologic therapy 2020 NovSizes of these terms reflect their relevance to your search.
A 6-year-old child with recessive dystrophic epidermolysis bullosa, confirmed by history, clinical exam, and antigen mapping, was treated with losartan with reduction in the blistering and better quality of life. © 2020 Wiley Periodicals LLC.
Citation
Arun C Inamadar. Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa. Dermatologic therapy. 2020 Nov;33(6):e14279
Mesh Tags
Substances
PMID: 32888385
View Full Text
